ArriVent BioPharma AVBP
NASDAQ AVBP
$19.12 +0.27 (+1.43%)
At close: Oct 21, 2026 · 4:00 PM EDT

ArriVent BioPharma (AVBP) Operating Leases (2023 - 2026)

Updated

ArriVent BioPharma (AVBP) posted Operating Leases of $33,000 for Q2 2026, down 89.7% from the prior quarter.

Analysis

ArriVent BioPharma (AVBP) Operating Leases (2023 - 2026) Analysis & Trends

At the end of FY2024, ArriVent BioPharma's Operating Leases came in at $14,000, down 92.1% from FY2023.

  • In prior years, ArriVent BioPharma's Operating Leases was $177,000 in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 ArriVent BioPharma 909.29 Mn -403.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33,000.00
Mar 31, 2026 320,000.00
Dec 31, 2024 14,000.00
Sep 30, 2024 56,000.00
Jun 30, 2024 98,000.00
Mar 31, 2024 138,000.00
Dec 31, 2023 177,000.00
API Access

ArriVent BioPharma Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=AVBP&period=max&api_key=YOUR_API_KEY